샘플 요청 목록

 카트 문의
시장보고서
상품코드
1536137

세계 첨단 약물전달 시스템 시장

Advanced Drug Delivery Systems
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 283 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

첨단 약물 전달 시스템 세계 시장은 2030년까지 3,624억 달러에 이를 것으로 예상

2023년에 2,511억 달러로 추정된 첨단 약물 전달 시스템 세계 시장은 분석 기간 2023-2030년에 CAGR 5.4%로 성장하고, 2030년에는 3,624억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 경구 약물 전달은 CAGR 6.2%로 성장을 지속하고, 분석 기간 종료 시 1,583억 달러에 도달할 것으로 예측됩니다. 폐 약물 전달 부문의 성장률은 분석 기간 동안 CAGR 5.7%로 추정됩니다.

미국 시장은 684억 달러로 추정, 중국은 CAGR 8.9%로 성장 예측

미국의 첨단 약물전달 시스템 시장은 2023년 684억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 765억 달러 규모에 이를 것으로 예측되며 분석 기간 2023-2030년의 CAGR은 8.9%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.1%와 5.5%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 3.3%로 성장할 것으로 예측됩니다.

세계 첨단 약물전달 시스템 시장 - 주요 동향과 촉진요인 정리

첨단 약물 전달 시스템(ADDS)은 의약 화합물의 투여 및 효능을 향상시키는 광범위한 기술을 포함합니다. 이러한 시스템은 부작용을 최소화하면서 약물을 질병 부위에 특이적으로 표적화하고, 약물 방출 속도를 제어하고, 치료 작용의 지속 시간을 연장하도록 설계되었습니다. ADDS의 주요 유형은 리포좀, 나노입자, 경피 패치, 임베디드 디바이스 등을 포함합니다. 예를 들어, 나노입자는 조직의 깊은 부분까지 침투하여 세포 수준으로 직접 약물을 전달할 수 있으며, 경피 패치는 피부에서 장기간에 걸쳐 약물을 방출합니다. 이러한 표적화된 접근법은 약물이 필요한 곳에 정확하게 작용하여 환자의 예후를 개선할 뿐만 아니라 필요한 총량을 줄임으로써 독성 잠재력을 줄일 수 있습니다.

이러한 시스템의 개발은 재료과학, 생명공학, 나노기술의 최신 발전에 큰 영향을 받고 있습니다. 연구자들은 신체와 안전하게 상호 작용하고 특정 생물학적 트리거에 반응하여 약물을 방출할 수 있는 새로운 물질을 지속적으로 탐구하고 있습니다. 예를 들어, 미리 결정된 속도로 용해되는 생분해성 중합체는 약물 용출 스텐트 및 임플란트의 제조에 사용됩니다. 나노기술 측면에서 덴드리머(고도로 분지된 별 모양의 고분자)는 암이나 감염과 같은 문제를 효과적으로 해결하기 위해 약물과 표적 분자를 부착시키는 유망한 프레임워크를 제공합니다. 하고 있습니다. 약물 수준과 환자의 건강 마커를 실시간으로 모니터링하는 센서를 포함한 ADDS에 스마트 기술의 통합도 증가하고 있습니다. 이러한 혁신은 실시간 데이터를 기반으로 환자 한 사람의 요구에 맞게 치료를 하는 보다 개별화된 의료 실천으로 이어지고 있습니다.

첨단 약물 전달 시스템 시장의 성장은 만성 질환의 부담 증가, 보다 효율적이고 편리한 치료 옵션에 대한 수요 증가, 의약 연구 개발에 많은 투자를 포함한 여러 요인에 의해 견인되고 있습니다. 당뇨병, 암, 심혈관 질환과 같은 만성 질환의 유행은 장기간에 걸쳐 복잡한 치료 요법을 필요로하기 때문에 치료 프로토콜을 단순화하고 어드레싱을 개선 할 수있는보다 효과적인 전달 시스템이 필요합니다. 라고합니다. 게다가, 개인화된 의료의 추진은 개별 환자의 요구에 적응할 수 있는 약물 전달 시스템에 대한 수요를 증가시키고 있습니다. 보다 진보적이고 낮은 침습적인 전달 옵션의 개척을 가능하게 하는 기술의 발전도 이 시장의 확대에 기여하고 있습니다. 또한, 예방 건강 관리에 대한 소비자 행동의 변화와 가정용 자동 주사기와 같은 치료의 자가 투여의 수용 확대는 ADDS의 성장을 더욱 촉진하고 있습니다. 이러한 요인이 겹치는 것으로, 첨단 약물전달 시스템은 세계의 헬스케어에 큰 영향을 줄 가능성을 비롯한, 다이나믹하고 급속하게 진화하는 분야가 되는 것입니다.

조사 대상 기업 예(전 86건)

  • Becton, Dickinson and Company
  • Cadence Inc.
  • Croda Pharma
  • DCA Design International Limited
  • Enable Injections, Inc.
  • Evonik Health Care
  • Gerresheimer AG
  • Kindeva Drug Delivery
  • Medmix Ltd.
  • SHL Medical AG
  • Sparsha Pharma International Pvt Ltd
  • SPI Pharma
  • SteriPack Group
  • Stevanato Group
  • Ypsomed AG;

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

JHS 24.08.29

Global Advanced Drug Delivery Systems Market to Reach US$362.4 Billion by 2030

The global market for Advanced Drug Delivery Systems estimated at US$251.1 Billion in the year 2023, is expected to reach US$362.4 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Oral Drug Delivery, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$158.3 Billion by the end of the analysis period. Growth in the Pulmonary Drug Delivery segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$68.4 Billion While China is Forecast to Grow at 8.9% CAGR

The Advanced Drug Delivery Systems market in the U.S. is estimated at US$68.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$76.5 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Advanced Drug Delivery Systems Market - Key Trends and Drivers Summarized

Advanced drug delivery systems (ADDS) encompass a broad range of technologies that enhance the administration and efficacy of pharmaceutical compounds. These systems are designed to target drugs specifically to disease sites, control the rate of drug release, and increase the duration of therapeutic action, all while minimizing side effects. Key types of ADDS include liposomes, nanoparticles, transdermal patches, and implantable devices. Each system has its own unique mechanism of action: for instance, nanoparticles can penetrate deep into tissues to deliver drugs directly to the cellular level, while transdermal patches release medication through the skin over an extended period. This targeted approach not only improves patient outcomes by ensuring that the drug acts precisely where it is needed but also reduces the overall dosage required, thereby decreasing the potential for toxicity.

The development of these systems is heavily influenced by the latest advances in materials science, biotechnology, and nanotechnology. Researchers are continually exploring new materials that can safely interact with the body and respond to specific biological triggers to release drugs. For example, biodegradable polymers that dissolve at pre-determined rates are used to fabricate drug-eluting stents and implants. On the nanotechnology front, dendrimers — highly branched, star-shaped macromolecules — offer promising frameworks for attaching drugs and targeting molecules to address issues like cancer and infectious diseases effectively. The integration of smart technology into ADDS, such as sensors that monitor drug levels and patient health markers in real time, is also on the rise. These innovations are leading to more personalized medicine practices, where treatments can be tailored to the individual needs of each patient based on real-time data.

The growth in the advanced drug delivery systems market is driven by several factors, including the increasing burden of chronic diseases, the rising demand for more efficient and convenient therapeutic options, and significant investments in pharmaceutical R&D. The prevalence of chronic conditions like diabetes, cancer, and cardiovascular diseases, which require prolonged and often complex treatment regimens, has led to a need for more effective delivery systems that can simplify treatment protocols and improve adherence. Moreover, the push towards personalized medicine is increasing the demand for drug delivery systems that are adaptable to individual patient requirements. Technological advancements that enable the development of more sophisticated and minimally invasive delivery options also contribute to the expansion of this market. Additionally, the consumer behavior shift towards preventive healthcare and the growing acceptance of self-administration of treatments, such as auto-injectors for home use, are further catalyzing the growth of ADDS. The convergence of these factors ensures that advanced drug delivery systems continue to represent a dynamic and rapidly evolving field with significant potential for impacting global healthcare practices.

Select Competitors (Total 86 Featured) -

  • Becton, Dickinson and Company
  • Cadence Inc.
  • Croda Pharma
  • DCA Design International Limited
  • Enable Injections, Inc.
  • Evonik Health Care
  • Gerresheimer AG
  • Kindeva Drug Delivery
  • Medmix Ltd.
  • SHL Medical AG
  • Sparsha Pharma International Pvt Ltd
  • SPI Pharma
  • SteriPack Group
  • Stevanato Group
  • Ypsomed AG;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Advanced Drug Delivery Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Nanotechnology Innovations Propel Development of Advanced Drug Delivery Systems
    • Rising Prevalence of Chronic Diseases Expands Addressable Market for Targeted Delivery Solutions
    • Patient-Centric Drug Development Trends Bolster Adoption of User-Friendly Drug Delivery Technologies
    • Expansion of Home Healthcare Market Sets the Stage for Ambulatory and Self-Administered Drug Delivery
    • Technological Breakthroughs in 3D Printing of Drug Delivery Devices Generate Market Opportunities
    • Global Diabetes Epidemic Spurs Development of Advanced Insulin Delivery Systems
    • Evolving Oncology Treatments Require Novel Drug Delivery Approaches
    • Shift Toward Non-Invasive Delivery Methods Spurs Product Innovation
    • Technological Integration in Drug Delivery Devices Fuels Development of Connected Medical Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Advanced Drug Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Advanced Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Advanced Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Oral Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Oral Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Oral Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pulmonary Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pulmonary Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Pulmonary Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Transdermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Transdermal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Parenteral Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Parenteral Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Parenteral Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Cardiology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Neurology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Neurology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Pulmonary Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Pulmonary Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Pulmonary Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • JAPAN
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • CHINA
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • EUROPE
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Advanced Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Advanced Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • FRANCE
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: France 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • GERMANY
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Advanced Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Advanced Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • INDIA
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: India 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Advanced Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Advanced Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Advanced Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Advanced Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030
  • AFRICA
    • Advanced Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Advanced Drug Delivery Systems by Type - Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Advanced Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Oral Drug Delivery, Pulmonary Drug Delivery, Transdermal Drug Delivery, Parenteral Drug Delivery and Other Types for the Years 2014, 2024 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Advanced Drug Delivery Systems by Application - Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Advanced Drug Delivery Systems by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology Application, Cardiology Application, Neurology Application and Pulmonary Application for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제